Continuing Education at the APHA Annual Meeting

2009 Annual Meeting CE Evaluation Center is Now Closed

_______________________________________________

            2010 APHA Annual Meeting and Exposition                    Social Justice: A Public Health Imperative

Scientific Session-  Hundreds of scientific sessions will be approved for continuing education credits for Certified Health Education Specialists (CHES), Continuing Medical Education (CME) and Continuing Nursing Education (CNE) and Certified in Public Health (CPHCE)

Learning Institute Courses - APHA also offers Learning Institute Courses immediately prior to the Conference.  Up to 13.5  CE credits can be earned for attending these half or full-day courses. (a separate registration fee is required) 

Educational Objectives

• To define the roles of the public health community in responding to the influences of physical, economic and social environments.
• To identify lessons learned and best practices in addressing general public health issues.
• To increase information about and general awareness of public health issues and how they are affected by immediate world factors.
• To enrich the work experiences of public health practitioners by introducing new skills and improving existing competencies.
• To provide both formal and informal opportunities for attendees to share ideas, information and experiences, and to promote alliances and networking to address public health issues.

Target Audience - Policy makers, physicians, social workers, health educators, public and environmental health professionals, state, county, and local health agency officials and staff; nurses and nurse practitioners, health care providers, and staff including those in schools, managed care, and academe.

Policy on Faculty and Sponsor Disclosure - It is the policy of APHA that the program planners, presenters, moderators and organizers disclose real or apparent conflicts of interest relating to their participation in the educational component of the Annual Meeting. They must also disclose discussions of unlabeled/unapproved (off-label) or experimental uses of drugs or devices during their presentation(s). Specific disclosure will be made in the online program, the hard copy program and at the beginning of each educational Institute or scientific session.